Delivery Order SPE2DB22D3016-SPE2DB26FABL4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,287.82 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $4,980.90 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order, issued without set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication primarily used to treat autoimmune and inflammatory conditions including...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,831.00 for TALTZ 80 mg/ml autoinjector on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly prescribed for autoimmune conditions including psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,670.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector (2-pack) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used in the treatment of autoimmune...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABL4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,463.75 for TALTZ 80 mg/ml autoinjector on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat autoimmune inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order represents a small-value transaction typical of routine pharmaceutical procurement under AmerisourceBergen's comprehensive global pharmaceutical support vehicle with DLA. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's competitively awarded contracts with DLA demonstrate its capability to meet federal requirements across multiple therapeutic domains and delivery formats, including specialty auto-injector medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 11/5/25 |